Furthermore, YAP/TEAD activity in human CRPC cohorts (via RNA signatures) was significantly reduced in NEPC compared to PRAD (Fig. 3I–3K), consistent with scRNA-seq data from a smaller CRPC cohort (28). Here, YAP1 is linked to prostate adenocarcinoma.